Literature DB >> 23894203

Does the awareness of terminal illness influence cancer patients' psycho-spiritual state, and their DNR signing: a survey in Taiwan.

Chi-Yin Kao1, Shao-Yi Cheng, Tai-Yuan Chiu, Ching-Yu Chen, Wen-Yu Hu.   

Abstract

OBJECTIVE: The aim of the study was to explore the relationships between truth telling, patients' psycho-spiritual state and do not resuscitate consent.
METHODS: Cancer patients who had consulted with hospice care at the National Taiwan University Hospital in Taipei were approached. Patients excluded from the study included those who were unable to give informed consent, not well enough to complete the questionnaire survey, would be discharged within 24 h or who could not communicate in Chinese or Taiwanese. The 90 patients recruited for the study were grouped according to their awareness of their terminal prognosis ('aware' or 'unaware'). A structured questionnaire was used for data collection, including questions on uncertainty, the Hospital Anxiety and Depression Scale and the Spiritual Well-being Scale.
RESULTS: Truth telling reduced cancer patients' uncertainty (P = 0.023) and anxiety (P = 0.005), and did not affect their state of spiritual well-being (P = 0.868). Before hospice referral, patients aware of their prognosis were more likely to sign the do not resuscitate consent (P = 0.040). In the aware group, 28% signed the do not resuscitate themselves, whereas in the unaware group, only 5% signed the do not resuscitate themselves (P = 0.031). The median time between signing the do not resuscitate and death was 29 days in the aware group and 16 days in the unaware group. Data revealed that 82% of the aware group died having given their do not resuscitate consent and did not receive a vasopressor or intubation, whereas only 52% of the unaware group died in this manner.
CONCLUSIONS: Truth telling can reduce cancer patients' uncertainty and anxiety. Patients aware of their prognosis tended to sign the do not resuscitate consent willingly and had more dignified and peaceful deaths.

Entities:  

Keywords:  DNR; anxiety; cancer; hospice care; terminal care

Mesh:

Year:  2013        PMID: 23894203     DOI: 10.1093/jjco/hyt095

Source DB:  PubMed          Journal:  Jpn J Clin Oncol        ISSN: 0368-2811            Impact factor:   3.019


  6 in total

1.  Do-not-resuscitate consent signed by patients indicates a more favorable quality of end-of-life care for patients with advanced cancer.

Authors:  Yi-Hsin Liang; Chih-Hsin Wei; Wen-Hui Hsu; Yu-Yun Shao; Ya-Chin Lin; Pei-Chun Chou; Ann-Lii Cheng; Kun-Huei Yeh
Journal:  Support Care Cancer       Date:  2016-10-04       Impact factor: 3.603

2.  For patients with terminal chronic illness, does more face-to-face time with a healthcare provider decrease aggressive end-of-life (EOL)care such as ICU admission, feeding tube placement, CPR, or intubation?

Authors:  Preston H Seaberg; Laine H McCarthy; Robert M Hamm
Journal:  J Okla State Med Assoc       Date:  2014-11

3.  Associations of prognostic-awareness-transition patterns with end-of-life care in cancer patients' last month.

Authors:  Chen Hsiu Chen; Fur-Hsing Wen; Wen-Chi Chou; Jen-Shi Chen; Wen-Cheng Chang; Chia-Hsun Hsieh; Siew Tzuh Tang
Journal:  Support Care Cancer       Date:  2022-04-08       Impact factor: 3.603

4.  Perceptions and practices of spiritual care among hospice physicians and nurses in a Taiwanese tertiary hospital: a qualitative study.

Authors:  Zoe Tao; Poshu Wu; Amber Luo; Tzu-Lin Ho; Ching-Yu Chen; Shao-Yi Cheng
Journal:  BMC Palliat Care       Date:  2020-07-01       Impact factor: 3.234

5.  Patient Factors Associated with Different Hospice Programs in Korea: Analyzing Healthcare Big Data.

Authors:  Young-Taek Park; Daekyun Kim; Su-Jin Koh; Yeon Sook Kim; Sang Mi Kim
Journal:  Int J Environ Res Public Health       Date:  2022-01-29       Impact factor: 3.390

6.  End-of-life decision-making of terminally ill cancer patients in a tertiary cancer center in Shanghai, China.

Authors:  Xiaoli Gu; Menglei Chen; Minghui Liu; Zhe Zhang; Wenwu Cheng
Journal:  Support Care Cancer       Date:  2015-11-14       Impact factor: 3.359

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.